A large coalition of business groups in Michigan announced opposition to two state House bills that are part of a 15-bill Republican health care reform package they say will increase insurance premiums.
The business groups are focusing opposition toand related to insulin and oral chemotherapy coverage they say will shift costs to small businesses and “mandate coverages and add unnecessary new regulations to insurers, raising health insurance premiums.”
A House spokesman told Crain’s that leadership expects to take up many of the bills today for a vote this afternoon.
The coalition includes the Michigan Association of Health Plans, Economic Alliance for Michigan, Small Business Association of Michigan, the Michigan Chamber of Commerce, Detroit Regional Chamber, Grand Rapids Area Chamber of Commerce and the National Federation of Independent Business.
The groups have scheduled a virtual news conference Thursday to further discuss the bills’ impact.
Dominick Pallone, MAHP’s executive director, outlined the coalition’s opposition to the two bills.
“The focus (of the GOP health reform package) is definitely on pharmaceutical costs. But some parts of this package are pretty toxic if you are an employer buying insurance,” said Pallone, noting that many of the 15 proposed bills have been previously discussed the past 10 years.
“You’ve got a bill that caps insulin costs and an oral chemotherapy provision (prohibiting health insurers from charging higher) copays for treatments. What this does is just squeeze the balloon and starts shifting prices and costs to employers.”
Already, Michigan’s small business insurance premiums are ninth highest in the nation and mandated coverage could reduce the number of small businesses that cover their workforce, said SBAM. Only about one-third of small businesses with fewer than 50 workers in Michigan cover their employees, the association said.
“These bills will increase those already high premiums at a time when small businesses are struggling,” said Scott Lyon, SBAM’s senior vice president, in an email to Crain’s.
Lyon estimated the bills will cost an additional $57 million in insurance premiums paid by state companies.
“These bills will mean more of those companies will face the difficult decision of cutting off insurance for their workers,” Lyon said.
Pallone said the two bills don’t impact health plans directly, but costs will be shifted to employers in the form of higher premiums for fully insured plans.
“It definitely harms the business community,” he said. “The politics is mind-boggling. It’s a populist approach and you have House Republicans shunning the traditional businesses that they historically try to help.”
Pallone said only 24 percent of the people covered under fully insured group policies or individual health insurance in Michigan would be affected.
In her 2020 State of the State speech, Gov. Gretchen Whitmer said reducing the costs of prescription drugs would be a key future focus. She said at the time, “We know that the increase in prescription drug costs has just been skyrocketing.”
The Democratic governor is supportive of the legislation that helps contain the cost of prescription drugs, Whitmer spokesman Bobby Leddy said Wednesday.
“The governor is pleased that the House is advancing bipartisan legislation to tackle the cost of prescription drugs,” Leddy said in an email to Crain’s. “No one should have to choose between filling their prescriptions, paying rent or putting food on the table.”
The proposed reforms in the House bills are in line with recommendations from a task force Whitmer formed last year within the Michigan Department of Health and Human Services that examined prescription drug costs and how prices are set, Leddy said.
“The task force’s recommendations, delivered in early 2021, take on greater urgency amidst the COVID-19 pandemic and we look forward to working in a bipartisan way with the Legislature to drive down costs and deliver affordable, accessible health care for Michigan families,” Leddy said.
Highlights of some of the other health reform bills include:
- Pharmacists would have more freedom to discuss medication options and pricing with patients.
- Ending the so-called “gag clauses” that prevent pharmacists from disclosing the prices of generic drugs comparable to those prescribed. Similar federal legislation, sponsored by U.S. Sen. Debbie Stabenow, D-Mich., was adopted in 2018.
- Require the pharmaceutical industry and pharmacy benefit managers to submit quarterly “transparency reports” and bans spread pricing that allows PBMs to recoup fees from drug companies intended for local pharmacies. Last December, the U.S. Supreme Court unanimously ruled that states can regulate the power of pharmacy benefit managers.
- Allow patients to shop for lower-priced medications. Now, some patients are penalized for purchasing prescriptions from out-of-network providers. The bill would allow patients to count money used out-of-network toward yearly out of pocket costs for in-network purchases. Other states have similar laws.
- Out-of-state telehealth providers would be allowed to market services and advise Michiganders.
- Doctors would have the amount of gifts they receive capped from outside vendors or pharmaceutical companies. Now, pharmaceutical representatives can give large gifts to doctors in Michigan, which is done to influence physician prescription choices.
Crain’s Senior Editor Chad Livengood contributed.